ADIAL PHARMACEUTICALS, INC. Net Income Loss

Quick Answer

ADIAL PHARMACEUTICALS, INC. reported Net Income Loss of -$7.98 million for the year ending 2025.

  • ADIAL PHARMACEUTICALS, INC. showed an increase of +39.6% in Net Income Loss from 2024 to 2025.
  • This data is from ADIAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), ADIAL PHARMACEUTICALS, INC.'s Net Income Loss has declined by 600.1%.
  • Historical annual values: Fiscal year 2025: -$7.98 million | Fiscal year 2024: -$13.20 million | Fiscal year 2023: -$5.12 million | Fiscal year 2022: -$12.73 million | Fiscal year 2021: -$19.42 million | Fiscal year 2020: -$10.89 million | Fiscal year 2019: -$8.59 million | Fiscal year 2018: -$11.63 million | Fiscal year 2017: -$1.14 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: